T. Rowe Price Investment Management, Inc. Rx Sight, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 719,818 shares of RXST stock, worth $9.61 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
719,818
Previous 73,027
885.69%
Holding current value
$9.61 Million
Previous $2.51 Million
623.86%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RXST
# of Institutions
202Shares Held
34.5MCall Options Held
269KPut Options Held
8.5K-
Ra Capital Management, L.P. Boston, MA3.74MShares$50 Million1.96% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$31.9 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.18MShares$29.2 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.77MShares$23.6 Million0.08% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $369M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...